![](/sites/default/files/styles/medium/public/oembed_thumbnails/hjb3rgge5KIKplHoDP_jUlgD6TQxUDP_kdw6VqwXuLs.jpg?itok=EnfI8ECs)
Dr. Mary-Ann Etiebet has two decades of experience improving healthcare outcomes for underserved populations and transforming healthcare delivery at the frontlines. She serves as AVP for Health Equity at Merck and the Lead of Merck for Mothers*, Merck's $500M global health initiative to help create a world where no woman has to die giving life. Since 2011, Merck for Mothers programs and partnerships have resulted in healthy pregnancies and safe deliveries for over 13M women in 50 countries. Building on her experiences as a physician, researcher, implementer, funder and advocate across the public, private and global development sectors, Dr. Etiebet brings a diverse set of perspectives to advancing health equity. She joined Merck from Premier Inc, where she was a Principal Consultant in the Population Health Management team. Her work in global health includes serving as the Senior Technical Advisor of the Institute of Human Virology-Nigeria, a PEPFAR implementing partner, while she was Assistant Professor, Division of Infectious Disease at the University of Maryland School of Medicine. Dr. Etiebet holds an MD and MBA from Yale University. She completed her residency in Internal Medicine at New York-Presbyterian Weill Cornell and fellowship in Infectious Diseases Hospital System at New York-Presbyterian Columbia University Medical Center, becoming Board Certified in both Internal Medicine and Infectious Diseases.